Lv1
76 积分 2023-04-14 加入
Abstract 3124: MRG006A, a novel glypican-3-targeting antibody-drug conjugate, demonstrated potent anti-tumor activity and good safety profile in preclinical studies
1年前
已关闭
Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact
1年前
已关闭
uPAR, beyond regulating physiological functions, has orchestrated roles in cancer (Review)
1年前
已完结
Targeting Urokinase-type plasminogen activator receptor (uPAR) in cancer therapy: Insights from the development of small-molecule inhibitors
1年前
已完结
suPAR as a biomarker of support in different clinical settings
1年前
已完结
Targeting Urokinase-type plasminogen activator receptor (uPAR) in cancer therapy: Insights from the development of small-molecule inhibitors
1年前
已完结
A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
1年前
已完结
Emerging role of the immunotherapy in treatment of breast cancer
1年前
已完结
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
1年前
已完结
Biological effects of IL-15 on immune cells and its potential for the treatment of cancer
1年前
已完结
皖公网安备34019202002308
